Clinical Trial Update: PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating procalcitonin-guided shortening of antibiotic duration in pediatric intensive care unit patients with sepsis (ProSho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Hunan Children's Hospital | Conditions: Sepsis | Phase 3 | Status: UNKNOWN